First Light Asset Management »

Organogenesis Hldgs shares owned by First Light Asset Management

Quarter-by-quarter ownership of Organogenesis Hldgs (ORGO) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Organogenesis Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Organogenesis Hldgs held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organogenesis Hldgs by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $32M 7.5M 4.22
2025-06-30 $25M 6.8M 3.66

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Performant Healthcare Common Stocks (PHLT)
Centessa Pharmaceuticals Common Stocks (CNTA)
Neogenomics Common Stocks (NEO)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Health Catalyst Common Stocks (HCAT)
Palvella Therapeutics Common Stocks (PVLA)
Twist Bioscience Corporation Common Stocks (TWST)
Lenz Therapeutics Common Stocks (LENZ)
Organogenesis Holdings Common Stocks (ORGO)
Atricure Common Stocks (ATRC)
Anaptys Bio Common Stocks (ANAB)
Si-bone Common Stocks (SIBN)
Cidara Therapeutics Common Stocks (CDTX)

View all positions for First Light Asset Management

Top funds holding Organogenesis Hldgs

Soleus Capital Management
Morgan Stanley
First Light Asset Management
Vanguard Group
Assenagon Asset Management
BlackRock
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Acadian Asset Management
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
Renaissance Technologies
AQR Capital Management
Northern Trust

View all funds holding Organogenesis Hldgs